We also carry separate copper peptides for hair tonics at 1% concentration
As of June 2026, FOXO4-DRI has no completed or registered human clinical trial
BPC-157 / TB-500 Blend Lyophilised Research Peptide UK BPC-157 / TB-500 Blend is a high-purity lyophilised research peptide combination supplied in a single sterile vial, containing a balanced split of BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 Fragment)
Clinicians often integrate the product with calorie-restricted diets, resistance training, and behavior-change counseling to potentially maximize adipose mass reduction while preserving lean tissue, though evidence remains largely extrapolated from the individual components pharmacology and not from randomized controlled trials of the exact compounded combination
It is an essential nutrient involved in gene regulation, neurotransmitter production, homocysteine conversion, cognitive function and many other processes that support the body and mind
Semaglutide 2.4mg (GLP-1 Agonist): Proven GLP-1 effects (appetite suppression, gastric emptying) Already FDA-approved as Wegovy Established safety profile Cagrilintide 2.4mg (Amylin Analog): Mimics amylin, a hormone co-secreted with insulin Slows gastric emptying through different pathway than GLP-1 Reduces appetite through hindbrain (not hypothalamus) Improves postprandial glucose The Advantage: Leverages proven semaglutide efficacy and safety, adds complementary amylin effects